+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Critical Care Adsorption Solutions Market by Product Type (Hemofiltration Adsorber, Hemoperfusion Cartridge, Plasma Adsorption Column), Application (Cytokine Storm, Drug Overdose, Liver Failure), End User, Technology, Adsorbent Material, Patient Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6078995
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Critical care adsorption solutions are redefining therapeutic strategies in acute and intensive care settings, providing hospital and health system leaders with adaptable technologies to target complex clinical challenges. These evolving platforms now enable precise toxin and cytokine removal, aligning with the urgent need for customizable interventions amid shifting healthcare landscapes, stringent regulatory updates, and surging patient complexity.

Market Snapshot: Growth, Drivers, and Competitive Lead in Critical Care Adsorption Solutions

The critical care adsorption solutions market continues to expand in response to escalating requirements around patient safety, cost containment, and management of emergent conditions. Product innovation in adsorption cartridges, regulatory influence, and a heightened focus on personalized patient profiles are accelerating adoption across leading medical centers, specialty clinics, and research institutes. Industry advances, from filtration technology to analytics integration, are enabling clinicians to deploy targeted therapies—including novel hemoperfusion and adsorption devices—for conditions such as sepsis, cytokine storm management, drug toxicity, and acute liver failure.

Scope & Segmentation

This comprehensive research report offers an in-depth, multi-dimensional view of the critical care adsorption solutions sector, covering product, application, end-user, technology, material, patient type, regional, and company-specific segmentation. Core coverage includes:

  • Product Types: Hemofiltration adsorbers (regenerative, synthetic), hemoperfusion cartridges (continuous flow, intermittent flow), plasma adsorption columns (broad-spectrum, polymyxin B-enabled).
  • Applications: Cytokine storms (including CAR-T therapy, COVID-19), drug overdose (acetaminophen, opioid), liver failure (acute, chronic), and sepsis cases (gram-negative, gram-positive).
  • End Users: Clinics, hospitals (teaching, non-teaching), research institutes.
  • Enabling Technologies: Extracorporeal systems (continuous, intermittent), intravascular devices (central, peripheral access), and digital monitoring integrations.
  • Materials: Activated carbon (granular, powdered), synthetic polymers (polymethyl methacrylate, styrene divinylbenzene), zeolites (clinoptilolite, mordenite).
  • Patient Types: Adult, neonatal (full term, preterm), pediatric (infant, toddler).
  • Regions: Americas (United States—including key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning Western Europe and key Middle Eastern & African nations), Asia-Pacific (China, India, Japan, Australia, and major Southeast Asian countries).
  • Company Developments: Strategic initiatives and product advancements from CytoSorbents Corporation, Toray Industries, Jafron Biomedical, Baxter International, Fresenius Medical Care, Asahi Kasei Medical, B. Braun Melsungen, Medtronic, Nikkiso, and Nipro Corporation.

Key Takeaways for Decision-Makers

  • Advancements in materials science and integration of digital monitoring have enhanced selectivity and real-time optimization of adsorption therapies across diverse care protocols.
  • The emergence of innovative adsorbent columns, including those utilizing advanced polymers and natural zeolites, allows precision targeting of pathogens and toxins while supporting safe application in neonatal and pediatric populations.
  • Clinical adoption is driven by expanded indications, from acute liver failure to public health emergencies, with collaborative partnerships accelerating the validation and deployment of novel devices.
  • Product differentiation increasingly hinges on cartridge design, compatibility with proprietary monitoring platforms, and alignment with outcome-based care models.
  • Regional growth opportunities are shaped by reimbursement frameworks, government funding and infrastructure readiness, with Asia-Pacific markets outpacing others due to substantial public and private healthcare investments.

Tariff Impact: Strategic Considerations in 2025

Recent United States tariff adjustments, effective in 2025, present considerable cost and supply chain challenges within the critical care adsorption solutions sector. Increased duties on imported cartridges and components drive manufacturers to rethink sourcing, while some industry players have initiated reshoring, pursued tariff exemptions, or deepened local supplier partnerships. Health providers are responding with long-term procurement contracts and strategic stockpiling to manage price volatility. These policy shifts reinforce the importance of agile operational models and robust cross-border collaborations throughout the critical care supply ecosystem.

Research Methodology & Data Sources

This report is informed by a rigorous, multi-stage research process. Secondary data were gathered from peer-reviewed publications, regulatory documents, and patent analyses. In-depth primary interviews with clinicians, device engineers, and supply chain leaders validated trends and unmet needs. Quantitative inputs were triangulated across sources to ensure data integrity, while subject matter experts contributed to a final validation round to confirm real-world market applicability.

Why This Report Matters

  • Enables C-suite and procurement leaders to appraise market dynamics, technology trajectories, and competitive positioning for future-ready investment strategies.
  • Supports clinical and operational decision-making with clear segmentation, ongoing innovation analysis, and region-specific adoption trends to optimize resource allocation and regulatory compliance.

Conclusion

Critical care adsorption solutions are reshaping acute patient management through ongoing technology and supply chain transformation. Stakeholders who anticipate regulatory, clinical, and regional developments will be positioned to lead in an evolving market defined by precision, agility, and collaborative innovation.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid integration of hemoadsorption cartridges in intensive care sepsis protocols to reduce cytokine storms
5.2. Expansion of point-of-care endotoxin adsorption devices in emergency departments for septic patients
5.3. Development of biocompatible polymer adsorbents for targeted cytokine removal with improved safety profiles
5.4. Strategic partnerships between device manufacturers and academic hospitals for clinical adsorption solution trials
5.5. Regulatory approvals driving broader adoption of extracorporeal adsorption systems in critical care units
5.6. Advances in custom adsorbent surface chemistry to enhance pathogen-specific removal from patient bloodstreams
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Critical Care Adsorption Solutions Market, by Product Type
8.1. Introduction
8.2. Hemofiltration Adsorber
8.2.1. Regenerative Filter
8.2.2. Synthetic Filter
8.3. Hemoperfusion Cartridge
8.3.1. Continuous Flow
8.3.2. Intermittent Flow
8.4. Plasma Adsorption Column
8.4.1. Cytosorb Cartridge
8.4.2. Polymyxin B Column
9. Critical Care Adsorption Solutions Market, by Application
9.1. Introduction
9.2. Cytokine Storm
9.2.1. CAR-T Therapy
9.2.2. COVID-19
9.3. Drug Overdose
9.3.1. Acetaminophen
9.3.2. Opioid
9.4. Liver Failure
9.4.1. Acute
9.4.2. Chronic
9.5. Sepsis
9.5.1. Gram Negative
9.5.2. Gram Positive
10. Critical Care Adsorption Solutions Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.3.1. Non-Teaching
10.3.2. Teaching
10.4. Research Institutes
11. Critical Care Adsorption Solutions Market, by Technology
11.1. Introduction
11.2. Extracorporeal
11.2.1. Continuous
11.2.2. Intermittent
11.3. Intravascular
11.3.1. Central
11.3.2. Peripheral
12. Critical Care Adsorption Solutions Market, by Adsorbent Material
12.1. Introduction
12.2. Activated Carbon
12.2.1. Granular
12.2.2. Powdered
12.3. Synthetic Polymer
12.3.1. Polymethyl Methacrylate
12.3.2. Styrene Divinylbenzene
12.4. Zeolites
12.4.1. Clinoptilolite
12.4.2. Mordenite
13. Critical Care Adsorption Solutions Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Neonatal
13.3.1. Full Term
13.3.2. Preterm
13.4. Pediatric
13.4.1. Infant
13.4.2. Toddler
14. Americas Critical Care Adsorption Solutions Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Critical Care Adsorption Solutions Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Critical Care Adsorption Solutions Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CytoSorbents Corporation
17.3.2. Toray Industries, Inc.
17.3.3. Jafron Biomedical Co., Ltd.
17.3.4. Baxter International, Inc.
17.3.5. Fresenius Medical Care AG & Co. KGaA
17.3.6. Asahi Kasei Medical Co., Ltd.
17.3.7. B. Braun Melsungen AG
17.3.8. Medtronic plc
17.3.9. Nikkiso Co., Ltd.
17.3.10. Nipro Corporation
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CRITICAL CARE ADSORPTION SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CRITICAL CARE ADSORPTION SOLUTIONS MARKET: RESEARCHAI
FIGURE 28. CRITICAL CARE ADSORPTION SOLUTIONS MARKET: RESEARCHSTATISTICS
FIGURE 29. CRITICAL CARE ADSORPTION SOLUTIONS MARKET: RESEARCHCONTACTS
FIGURE 30. CRITICAL CARE ADSORPTION SOLUTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGENERATIVE FILTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGENERATIVE FILTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC FILTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC FILTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOSORB CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOSORB CARTRIDGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMYXIN B COLUMN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMYXIN B COLUMN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OPIOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OPIOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NON-TEACHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NON-TEACHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TEACHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TEACHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CENTRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CENTRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRANULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRANULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POWDERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POWDERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMETHYL METHACRYLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMETHYL METHACRYLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STYRENE DIVINYLBENZENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STYRENE DIVINYLBENZENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINOPTILOLITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINOPTILOLITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MORDENITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MORDENITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY FULL TERM, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY FULL TERM, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRETERM, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRETERM, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TODDLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TODDLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 235. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2024 (USD MILLION)
TABLE 238. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2025-2030 (USD MILLION)
TABLE 239. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2024 (USD MILLION)
TABLE 240. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2025-2030 (USD MILLION)
TABLE 241. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2024 (USD MILLION)
TABLE 242. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2025-2030 (USD MILLION)
TABLE 243. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2024 (USD MILLION)
TABLE 246. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2025-2030 (USD MILLION)
TABLE 247. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2024 (USD MILLION)
TABLE 248. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2025-2030 (USD MILLION)
TABLE 249. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2024 (USD MILLION)
TABLE 250. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2025-2030 (USD MILLION)
TABLE 251. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2024 (USD MILLION)
TABLE 252. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2025-2030 (USD MILLION)
TABLE 253. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2024 (USD MILLION)
TABLE 260. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2025-2030 (USD MILLION)
TABLE 261. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2024 (USD MILLION)
TABLE 262. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2025-2030 (USD MILLION)
TABLE 263. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2024 (USD MILLION)
TABLE 264. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2025-2030 (USD MILLION)
TABLE 265. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2024 (USD MILLION)
TABLE 266. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2025-2030 (USD MILLION)
TABLE 267. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 268. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 269. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2024 (USD MILLION)
TABLE 270. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2025-2030 (USD MILLION)
TABLE 271. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 274. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 275. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 276. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 277. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2024 (USD MILLION)
TABLE 280. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2025-2030 (USD MILLION)
TABLE 281. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2024 (USD MILLION)
TABLE 282. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2025-2030 (USD MILLION)
TABLE 283. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2024 (USD MILLION)
TABLE 284. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2025-2030 (USD MILLION)
TABLE 285. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2024 (USD MILLION)
TABLE 288. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2025-2030 (USD MILLION)
TABLE 289. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2024 (USD MILLION)
TABLE 292. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2025-2030 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Critical Care Adsorption Solutions market report include:
  • CytoSorbents Corporation
  • Toray Industries, Inc.
  • Jafron Biomedical Co., Ltd.
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation